CDC report highlights the gaps in care of hepatitis C treatment

The prevalence of hepatitis C virus clearance was only 34% overall and even lower in individuals between 20 and 39 years of age.

Merck signs small acquisition to make ADCs safer

Antibody-drug conjugates have caught the biopharma world by storm, and Merck has been an active dealmaker in the space via multibillion-dollar pacts with Daiichi Sankyo

April 9, 2024

David Nutt On The Hope For Mental Health Treatment

In this Psychedelic Exclusive, we welcome Professor David Nutt, neuropsychopharmacologist, to The Dales Report’s table. Nutt specializes in drug research and conditions that affect the

October 13, 2023

FDA continues crackdown on plastic syringes made in China

The U.S. Food and Drug Administration has cracked down on imports of plastic syringes from China as the agency has raised concerns about quality issues.

July 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.